Boal becomes CBO
16.01.2013 - OBN, the trade association building the community for UK Bioscience companies, has named David Boal as Director of Business Development.
Boal joins OBN with an admirable sales record having worked with many of the major bioscience players and his own very successful consultancy. He graduated from the University of Ulster with a degree in Biomedical Sciences obtained whilst working at the MS research laboratories of Queens University in Belfast. Over the past 25 years David has achieved significant success in a number of sales, marketing and business development roles all within the Bio-pharmaceutical arena for companies such as, GD Searle (now Pfizer where he held a number of Sales & Marketing positions, Scotia, PolyMasc (Valentis), Laxdale and Amarin Neuroscience. Finally in the last 3 years, Boal has been running and managing his own business development consulting company (Diligent Consulting Ltd).http://www.european-biotechnology-news.com/people/bio-people/2013-01/david-boal.html